Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT) Deficiency: Effect of Dietary Purines on Enzyme Activity

  • W. J. Arnold
  • W. N. Kelley
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 41A)


The X-linked, virtually complete deficiency of hypoxanthineguanine phosphoribosyltransferase (HGPRT) activity results in a bizarre neurologic disorder, the Lesch-Nyhan syndrome (Seegmiller, Rosenbloom and Kelley, 1967). In initial reports HGPRT activity was noted as undetectable in erythrocytes from patients with the Lesch-Nyhan syndrome. However, more recently several investigators have noted low but detectable levels of HGPRT activity in erythrocytes from these patients (Mizuno, et al., 1970; Sorenson, 1970). In addition, it is now known that despite this striking reduction in HGPRT activity there is a normal amount of immunologically detectable HGPRT protein present (Rubin, et al., 1971; Arnold, Meade and Kelley 1972). We subsequently found that a given patient would also exhibit a wide variability in HGPRT activity even when assay conditions were standardized. This suggested that envir- onmental factors might be responsible for changes in enzyme actiivty and that one potential approach to therapy of patients with this disease would be activation of the structurally abnormal HGPRT protein. The present report describes the influence of alterations in dietary purine content on the erythrocyte HGPRT activity from three patients with the Lesch-Nyhan syndrome.


Complete Deficiency Dietary Purine Aminoimidazole Carboxamide HGPRT Activity Onmental Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arnold, W. J., Meade, J. C., and Kelley, W. N. 1972. Hypoxanthineguanine phosphoribosyltransferase: Characteristics of the mutant enzyme in erythrocytes from patients with the LeschNyhan syndrome. J. Clin. Invest. 51: 1805–1812.Google Scholar
  2. Arnold, W.J. and Kelley, W.N. 1973. Dietary-induced variation of hypoxanthine-guanine phosphoribosyltransferase activity in patients with the Lesch-Nyhan syndrome. J. Clin. Invest. 52: 970–973.Google Scholar
  3. Bakay, B. and Nyhan, W.L. 1972. Activation of variants of hypoxanthine-guanine phosphoribosyltransferase by normal enzyme. Proc. Nat. Acad. Sci. ( U.S.A. ). 69: 2523–2527.Google Scholar
  4. Mizuno, T., Segawa, M., Kurumada, T., Maruyama, H. and Onisawa, J. 1970. Clinical and therapeutic aspects of the Lesch-Nyhan syndrome in Japanese children. Neuropaediatrie. 2: 38–52.CrossRefGoogle Scholar
  5. Rubin, C.S., Dancis, J., Yip, L.C., Nowinski, R.C. and Balis, M.E. 1971. Purification of IMP: Pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease. Proc. Nat. Acad. Sci. ( U.S.A. ) 68: 1461–1464.Google Scholar
  6. Schulman, J.D., Greene, M.L., Fujimoto, W.Y. and Seegmiller, J.E. 1971. Adenine therapy for Lesch-Nyhan syndrome. Pediat. Res. 5: 77–82.Google Scholar
  7. Seegmiller, J.E., Rosenbloom, F.M. and Kelley, W.N. 1967. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155: 1682–1684.PubMedCrossRefGoogle Scholar
  8. Sorensen, L.B. 1970. Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency. J. Clin. Invest. 49: 968–978.Google Scholar

Copyright information

© Plenum Press, New York 1974

Authors and Affiliations

  • W. J. Arnold
    • 1
  • W. N. Kelley
    • 1
  1. 1.Department of MedicineDuke University Medical CenterDurhamUSA

Personalised recommendations